CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
Ropivacaine +1 moredrug
Likely dose
Ropivacaine 30 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02393677
NCT02393677N/ACompleted
CompareCT.gov

Supraclavicular Brachial Plexus Block Using Ropivacaine Alone or Combined With Dexmedetomidine for Upper Limb Surgery: A Prospective, Randomized, Double-blinded, Comparative Study

Government Medical College, Haldwani·interventional·Posted Mar 19, 2015·Updated Nov 6, 2015

In Brief

A clinical study evaluating Ropivacaine and Ropivacaine with Dexmedetomidine for Brachial Plexus Anesthesia. Completed, enrolled 80 participants.

Detailed Summary

80 American Society of Anesthesiologists (ASA) grade I-II patients, 18-60 years old,scheduled for elective upper limb orthopaedic surgery under supraclavicular brachial plexus block, were included in this prospective study. The patients were randomly assigned to group R (Ropivacaine alone) and group RD (Ropivacaine and dexmedetomidine) (40 patients in each group). Group R received Ropivacaine 0.50% (30 cc) + placebo and group RD received Ropivacaine 0.50% (30 cc) + dexmedetomidine 1 µg/kg.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBrachial Plexus Anesthesia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 19, 2015
Enrollment StartJul 1, 2011
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.3 years ago

Interventions

Ropivacainedrug

Ropivacaine 0.5% 30 ml was used to block brachial plexus

Ropivacaine with Dexmedetomidinedrug

Dexmedetomidine 1 microgram per kilogram bodyweight was added with 30 ml 0.5% Ropivacaine to block brachial plexus